67 DKTK Munich Cancer Colloquium

The 67 DKTK Munich Cancer Colloquium will be held on April 7, 2025. 

Agenda: 

• 17:00-17:30 
  Exploiting tumour intrinsic vulnerabilities in NSCLC via the ubiquitin system 
  Markus E. Diefenbacher (Univ.-Prof.) 
  

  LMU Professor of Immuno-Oncology of the Lung and Pleura; Head of Helmholtz Research Group “Experimental Oncology”; LHI (Institute for Lung Heath and Immunity) / CPC (Comprehensive Pneumology Center)
  
  

• 17:30-17:45
  Radiotherapy for spinal metastases – current evidence, patterns of care and strategies for therapy optimization
  Dr. med. Maria Waltenberger
  Dienst für onkologische Strahlentherapie des Südtiroler Sanitätsbetriebs, Bozen, Italien
  former Fellow of the DKTK School of Oncology and Department of RadioOnkology at TUM University Hospital
  
  
• 17:45-18:00
  Deciphering the impact of the bone marrow niche on the evolution from clonal hematopoiesis to AML
  Dr. med. Frank Ziemann
  

  Department of Internal Medicine III, LMU Klinikum; former Fellow of the DKTK School of Oncology
  
  

• DKTK News
  . Update from the DKTK Scientific Community Meeting
  . Update on the DKTK Evaluation
  

Login at
https://dkfz-de.zoom-x.de/j/67906072570?pwd=wBtvdvFOayJzGD8bqxbLCbcObZE818.1 
Meeting ID: 679 0607 2570  and  Kenncode: DKTK67MCC

key words: lung, radiation, therapy